Dan Rozenfeld is a Managing Director in Blackstone’s Private Equity Group. Mr. Rozenfeld worked at Blackstone from 2014 to 2016 and, following the completion of an MBA, rejoined Blackstone in 2018. Since joining Blackstone in 2014, Mr. Rozenfeld has been involved in Blackstone’s investments in Copeland, Precision Medicine Group, HealthEdge, Signature Aviation, MB Aerospace, and NCR.

Before joining the Private Equity group in 2014, Mr. Rozenfeld worked in Consumer & Retail investment banking at Goldman Sachs.

Mr. Rozenfeld received an AB in Economics with a minor in Mathematical Finance from Dartmouth College, where he graduated summa cum laude and was elected to Phi Beta Kappa, and an MBA with Distinction from Harvard Business School.